J Korean Med Sci.  2023 Aug;38(32):e262. 10.3346/jkms.2023.38.e262.

Case 13: A 60-Year-Old Woman Presented With Dyspnea and Generalized Edema

Affiliations
  • 1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 2Catholic Research Institute for Intractable Cardiovascular Disease (CRID), College of Medicine, The Catholic University of Korea, Seoul, Korea


Figure

  • Fig. 1 Chest ap X-ray image of the patient at the time of emergency room visit.

  • Fig. 2 Systolic anterior movement through M-mode is seen in transthoracic echocardiogram (parasteral short axis view) (left picture), left ventricular outflow tract peak pressure gradient 119 mmHg, meanPG 42 mmHg (left picture).

  • Fig. 3 The septal branch of the target coronary artery was confirmed for echo contrast (left), and alcohol embolization was performed in the pacemaker insertion state (right).

  • Fig. 4 ECG rhythm of pre-procedure right bundle branch block pattern (left), ECG of patient changed to left bundle branch block after alcohol embolization (right).ECG = electrocardiogram.


Reference

1. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142(25):e558–e631. PMID: 33215931.
2. Cui H, Schaff HV, Wang S, Lahr BD, Rowin EJ, Rastegar H, et al. Survival following alcohol septal ablation or septal myectomy for patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2022; 79(17):1647–1655. PMID: 35483751.
3. Arévalos V, Rodríguez-Arias JJ, Brugaletta S, Micari A, Costa F, Freixa X, et al. Alcohol septal ablation: an option on the rise in hypertrophic obstructive cardiomyopathy. J Clin Med. 2021; 10(11):2276. PMID: 34073940.
4. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013; 381(9862):242–255. PMID: 22874472.
5. Heitner SB, Jacoby D, Lester SJ, Owens A, Wang A, Zhang D, et al. Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial. Ann Intern Med. 2019; 170(11):741–748. PMID: 31035291.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr